...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Context on Sales Potential for an oral anti-viral & anti-inflammation combo

Tada

Recently you indicated in a post that you had done some financial models projecting apabetalone revenue. Do you have any revenue projections on DM's proposed rollout of a $5 per pill, two pill per day therapy for Covid-19 and variants - presumably 5-10 days per patient?

Only revenue will move this stock. 

JMO

 

Share
New Message
Please login to post a reply